Chimerix reported $15.21M in Current Liabilities for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Ardelyx ARDX:US $ 47.84M 4.98M
Chimerix CMRX:US $ 15.21M 14.68M
Curis CRIS:US $ 9.69M 3.75M
Dynavax Technologies DVAX:US $ 466.2M 90.2M
Emergent Biosolutions EBS:US $ 249.2M 124.6M
Epizyme EPZM:US $ 38.97M 6.23M
Gilead Sciences GILD:US $ 8558M 3052M
Glaxosmithkline GSK:US $ 24278M 608M
Life Technologies LIFE:US $ 6.27M 0.26M
Merk MRK:US $ 22316M 1556M
Mirati Therapeutics MRTX:US $ 123.57M 20.09M
Novavax NVAX:US $ 2261M 129.31M
Xoma XOMA:US $ 7.89M 5.08M